Hin Hui Announces Dividend Distribution by Key Subsidiary Hin Hui Tianli (Hangzhou) Pharmaceutical Co., Ltd.
NQ Score
43/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Hin Hui Tianli (Hangzhou) Pharmaceutical Co., Ltd., a key subsidiary of Hin Hui, has resolved to distribute a cash dividend of USD 3 million for the 2025 fiscal year.
AI Analysis
Frequently Asked Questions
- Q: What is the dividend amount announced by Hin Hui Tianli (Hangzhou)?
- A: A cash dividend of USD 3 million for the 2025 fiscal year.
- Q: Which fiscal year does this dividend reflect?
- A: It is based on the financial performance of the 2025 fiscal year.
- Q: Where is the company located?
- A: It is based in Hangzhou, Zhejiang Province, China, as a key subsidiary of Hin Hui.